Last C$1.10 CAD
Change Today +0.04 / 3.77%
Volume 400.0
IM On Other Exchanges
Symbol
Exchange
Toronto
NASDAQ GS
Frankfurt
As of 3:57 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

imris inc (IM) Snapshot

Open
C$1.08
Previous Close
C$1.06
Day High
C$1.10
Day Low
C$1.08
52 Week High
08/12/13 - C$3.52
52 Week Low
06/5/14 - C$0.86
Market Cap
57.2M
Average Volume 10 Days
12.9K
EPS TTM
C$-0.79
Shares Outstanding
52.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IMRIS INC (IM)

Related News

No related news articles were found.

imris inc (IM) Related Businessweek News

No Related Businessweek News Found

imris inc (IM) Details

IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions that enable surgeons to obtain information and make decisions during the course of procedures. The company offers VISIUS Surgical Theatres, which deliver detailed visual information to clinicians during the course of various traditional surgical procedures that is used for various surgical applications, such as neurological, cardiovascular, cerebrovascular, interventional, and spine. The company’s products in development include magnetic resonance (MR) guided radiation therapy systems for use in MR imaging during radiotherapy treatments for cancer; and image guided surgical robotic systems for use in neurosurgical procedures. The company serves hospitals worldwide. IMRIS Inc. is based in Winnipeg, Canada.

137 Employees
Last Reported Date: 03/4/14

imris inc (IM) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $421.0K
Executive Chairman
Total Annual Compensation: $253.8K
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: $286.4K
Executive Vice President of Operations
Total Annual Compensation: $250.0K
Chief Technical Officer and Executive Vice Pr...
Total Annual Compensation: $276.7K
Compensation as of Fiscal Year 2013.

imris inc (IM) Key Developments

Imris, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2014; Provides Earnings Guidance for 2014

IMRIS, Inc. reported unaudited earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported sales of $8,151,000 compared with $8,066,000 for the same period last year. Adjusted LBITDA $4,916,000 compared with $6,372,000 for the same period last year. Operating loss was $6,119,000 compared with $7,774,000 for the same period last year. Net loss was $7,901,000 or $0.15 basic and diluted per share compared with $8,378,000 or $0.18 basic and diluted per share for the same period last year. IMRIS' net loss in the 2014 first quarter narrowed, the improvement was chiefly due to lower operating expenses of $2.8 million, partially offset by higher interest and other expense of $1.0 million, unfavorable foreign exchange impact of $0.2 million and lower gross profit of $1.1 million. Adjusted EBITDA for the 2014 first quarter was negative $4.9 million compared with negative $6.4 million for the same period last year. Adjusted EBITDA for the 2014 first quarter reflects lower gross profit and operating expenses, and higher interest expense. In 2014, the company will continue to execute its strategic plans, in order to set the stage for growth in 2015 and beyond. In addition to offering a broader product range, including a growing disposables business, it plan to continue building momentum for its VISIUS iCT and service sales. The company continues to anticipate that its 2014 second quarter revenues will be in the range of $3.5 million to $4 million, and the strongest quarterly revenue performance will occur in the second half of 2014. Gross profit as a percentage of sales is forecast to be approximately 40% for the full year 2014. Quarterly gross profit as a percentage of sales will vary depending on the underlying system installations in each quarter. While IMRIS does not provide earnings guidance, the Company does expect to be cash flow neutral in 2014. Depreciation is expected to be $4.0 million. Total capital expenditures in 2014 are expected to be in the range of $1.5 million to $2.5 million.

IMRIS, Inc. - Shareholder/Analyst Call

Annual general meeting

IMRIS, Inc. to Report Q1, 2014 Results on May 13, 2014

IMRIS, Inc. announced that they will report Q1, 2014 results at 9:00 AM, Eastern Standard Time on May 13, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IM:CN C$1.10 CAD +0.04

IM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
General Electric Co $26.55 USD +0.35
Koninklijke Philips NV €23.15 EUR 0.00
Medtronic Inc $63.79 USD +0.32
Siemens AG €92.49 EUR -0.50
View Industry Companies
 

Industry Analysis

IM

Industry Average

Valuation IM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.1x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMRIS INC, please visit www.imris.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.